Cellosaurus logo
expasy logo

Cellosaurus LIV27 (CVCL_C4LN)

[Text][XML][JSON]
Cell line name LIV27
Accession CVCL_C4LN
Resource Identification Initiative To cite this cell line use: LIV27 (RRID:CVCL_C4LN)
Comments Population: Caucasian.
Characteristics: Established from a nude mouse xenograft.
Characteristics: Highly tumorigenic.
Doubling time: 57.8 hours (Note=At 14th passage) (PubMed=36291862).
Derived from site: In situ; Liver; UBERON=UBERON_0002107.
Disease Intrahepatic cholangiocarcinoma (NCIt: C35417)
Cholangiocarcinoma (ORDO: Orphanet_70567)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 67Y
Category Cancer cell line
STR profile Source(s): PubMed=36291862

Markers:
AmelogeninX
CSF1PO10,12
D5S81813
D7S8208,14
D13S31711,13
D16S5398,12
D21S1129
TH019,9.3
TPOX8
vWA14,19

Run an STR similarity search on this cell line
Publications

PubMed=26956050; DOI=10.18632/oncotarget.7914; PMCID=PMC4991440
Xi-Wei Ding, Roongruedee Chaiteerakij, Catherine D. Moser, Hassan M. Shaleh, Jeffrey Boakye, Gang Chen, Albert Ndzengue, Ying Li, Yan-Ling Zhou, Sheng-Bing Huang, Frank A. Sinicrope ...Show all 15 authors... , Xiao-Ping Zou, Melanie Byrne Thomas, Charles D. Smith, Lewis Rowland Roberts; Show fewer authors
Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells.
Oncotarget 7:20080-20092(2016)

PubMed=36291862; DOI=10.3390/cancers14205080; PMCID=PMC9600735
Xi-Wei Ding, Kais Zakharia, Catherine D. Moser, Nellie A. Campbell, Chun-Ling Hu, Nataliya Razumilava, Roongruedee Chaiteerakij, Hassan M. Shaleh, Patricia T. Greipp, Rondell Patrell Graham, Xiao-Ping Zou ...Show all 13 authors... , Vishal Suresh Chandan, Lewis Rowland Roberts; Show fewer authors
Establishment and characterization of a new human intrahepatic cholangiocarcinoma cell line LIV27.
Cancers (Basel) 14:5080.1-5080.10(2022)

Cross-references
Encyclopedic resources Wikidata; Q116049708
Entry history
Entry creation15-Dec-2022
Last entry update29-Jun-2023
Version number3